Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xarelto
Xarelto
J&J and Bayer's Xarelto proves its worth across PAD subgroups in 2 new analyses
Fierce Pharma
Tue, 11/14/23 - 09:56 pm
JNJ
Bayer
Xarelto
blood thinners
AHA
peripheral artery disease
Anthos hails win over Xarelto with novel anticoagulant
Pharmaphorum
Mon, 09/18/23 - 09:56 am
Anthos Therapeutics
clinical trials
abelacimab
Xarelto
anticoagulants
atrial fibrillation
Rivaroxaban reduces adverse kidney events in atrial fibrillation patients with CKD
Clinical Trials Arena
Mon, 03/13/23 - 10:03 am
ACC
real world data
Xarelto
atrial fibrillation
ESC 2022 preview – who’s got the XI factor?
EP Vantage
Tue, 08/23/22 - 10:23 am
ESC 2022
Bristol Myers Squibb
JNJ
Bayer
Eliquis
Xarelto
bloodthinners
Lixiana
Pradaxa
Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report
Fierce Pharma
Tue, 06/14/22 - 08:57 pm
JNJ
Xarelto
Bristol Myers Squibb
Eliquis
drug pricing
blood thinners
FTC
With Bayer's new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long?
Fierce Pharma
Tue, 03/1/22 - 10:04 pm
Bayer
Eylea
Xarelto
drug launches
J&J, Bayer's Xarelto scores FDA nod in post-surgery artery disease as partners try to catch up with Eliquis
Fierce Pharma
Tue, 08/24/21 - 10:54 pm
Pfizer
Bristol Myers Squibb
Bayer
JNJ
Xarelto
FDA
Eliquis
ACC 2021: J&J, Bayer pad case for Xarelto in post-surgery artery disease patients
Fierce Pharma
Sun, 05/16/21 - 11:32 pm
Bayer
JNJ
ACC
Xarelto
bloodthinners
Bayer unveils first look at its post-Xarelto, post-Eylea life—and it's better than expected
Fierce Pharma
Wed, 03/10/21 - 10:49 pm
Bayer
Xarelto
Eylea
patents
Stivarga
Verquvo
ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study
Fierce Pharma
Mon, 08/31/20 - 10:49 am
Pfizer
Bristol-Myers Squibb
Eliquis
Xarelto
site-specific bleeding
RWE
ESC
ACC: J&J, Bayer's blood thinner Xarelto scores in artery disease post-surgery
Fierce Pharma
Sat, 03/28/20 - 11:27 pm
Xarelto
JNJ
ACC
clinical trials
peripheral artery disease
J&J's Xarelto, Amarin's Vascepa are cost-effective, not budget friendly — ICER
Endpoints
Fri, 10/18/19 - 10:18 am
ICER
drug pricing
JNJ
Xarelto
Amarin
Vascepa
FDA OKs new use for J&J's Xarelto
Seeking Alpha
Mon, 10/14/19 - 09:55 am
JNJ
Xarelto
venous thromboembolism
FDA
Xarelto falls into the donut hole
Biopharma Dive
Tue, 07/16/19 - 11:05 pm
JNJ
Xarelto
Medicare
J&J Takes Hits on Talc Lawsuit, Settles Xarelto Suit, Faces Pricing Criticism
BioSpace
Fri, 05/10/19 - 05:56 pm
JNJ
Xarelto
drug pricing
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Fierce Pharma
Tue, 04/23/19 - 12:10 pm
Bayer
JNJ
Xarelto
bloodthinners
Bristol-Myers Squibb
Pfizer
Eliquis
Price checked: J&J launches industry-first TV ad with drug list price
Fierce Biotech
Fri, 03/29/19 - 11:57 pm
JNJ
Xarelto
drug pricing
television ads
DTC ads
Bayer and J&J settle Xarelto lawsuits in US
Pharmaforum
Tue, 03/26/19 - 09:37 am
Bayer
JNJ
Xarelto
With Bayer predicting slowdowns for Xarelto and Eylea, what will fill the gap?
Fierce Pharma
Wed, 02/27/19 - 07:15 pm
Bayer
Xarelto
Eylea
Discounting hit J&J's Xarelto hard. Can a new launch turn things around?
Fierce Pharma
Tue, 01/22/19 - 11:56 pm
JNJ
earnings
Xarelto
Pages
1
2
3
4
5
6
7
8
9
next ›
last »